Evaluation of Sonographic Prostate Volume in Relation with International Prostate Symptom Score.

Introduction The International Prostate Symptoms Score (IPSS) may be used to measure the severity of lower urinary tract symptoms. To assess baseline patient pain, IPSS uses a seven-point questionnaire with a maximum total possible score of 35. IPSS is also used to monitor a patient's symptom improvement. Materials and Procedures: The current prospective investigation was carried out at our tertiary care hospital's Department of General surgery and department of radiodiagnosis. The research lasted six months, from January to June 2022. At 95% confidence interval and 5% acceptable margin of error, a sample size of 100 was computed. The research included patients with lower urinary tract complaints. Transabdominal ultrasonography was performed on all patients to determine prostate size/volume. The current research divides study participants into three groups based on the severity of their symptoms as determined by the IPSS score. 22% of the patients had mild symptoms, 40% had moderate symptoms, and 28% had severe symptoms. Prolate ellipsoid formula Antero-posterior x Transverse x Cranio-caudal x 0.52 was used to determine prostate volume. 12% of patients had a prostatic volume of 20 cc, 26% had a prostatic volume of 21-30 cc (Grade I), 34% had a prostatic volume of 31-50 cc (Grade II), 21% had a prostatic volume of 51-80 cc (Grade III), and 7% had an 80 cc (Grade IV). Conclusion We concluded from the current research that there was no association between age and international prostate symptom score, nor was there any correlation between prostate volume or prostate enlargement grade and IPSS score. [ABSTRACT FROM AUTHOR]